Classified as a selective Nicotinamide N-methyltransferase (NNMT) small-molecule inhibitor, this quaternary ammonium compound achieves around 38.4% oral bioavailability in rodent trials, an acceptable absorption rate for positively charged quinolinium derivatives that typically face poor intestinal permeability
How It Works (The Patient Journey & Dosing) Streamlined Care Delivered to Your Door Getting started with advanced hormone support is secure and straightforward
dysfunctions or hyperfunctions of somatosensory nerves, in particular sensory neuropathy, postherpetic neuralgia, atopic dermatitis, impaired healing of injured tissue, acquired cold and heat urticaria, psoriasis, bullous pemphigoid, eczema, photodermatoses, chronic arthritis, gastrointestinal lesions and specific or non-specific hyperreactivity of upper and lower respiratory tracts (asthma, rhinitis)
All therapies are overseen by experienced medical professionals and monitored for effectiveness and safety